Search results for "Drug safety"
Different patients, different doses
Some patients may metabolize certain drugs differently, requiring primary care physicians to know any safety or dosing issues for the most commonly used drugs.
https://immattersacp.org/archives/2019/05/different-patients-different-doses.htm
1 May 2019
Ondansetron 32-mg dose pulled from market
The 32-mg, single intravenous dose of ondansetron hydrochloride (Zofran) has been pulled from the market due to its cardiac risks, the FDA recently announced.
https://immattersacp.org/weekly/archives/2012/12/11/9.htm
11 Dec 2012
Trainees take charge at Leadership Day 2019
Nearly 400 physicians and future doctors from 48 states and Washington, D.C., focused on core priorities of ACP policy during more than 415 meetings with members of Congress and their staff.
https://immattersacp.org/archives/2019/07/trainees-take-charge-at-leadership-day-2019.htm
1 Jul 2019
New opioid warnings, powdered glove ban
The FDA announced plans to add new warnings to opioids and to ban powdered medical gloves last week.
https://immattersacp.org/weekly/archives/2016/03/29/6.htm
29 Mar 2016
Dumping drugs puts traces of meds in taps
How can you keep the contents of one patient's medicine cabinet from getting into everyone's drinking water? Eventually, physicians could even be asked to pay attention to environmental impact when deciding which drugs to prescribe.
https://immattersacp.org/archives/2009/02/drugs.htm
1 Feb 2009
Anxiolytic, hypnotic drugs may be associated with increased long-term mortality
Anxiolytic and hypnotic drugs may be associated with increased long-term mortality, according to a new study.
https://immattersacp.org/weekly/archives/2014/04/01/6.htm
1 Apr 2014
Safe prescribing can lessen overdose risk
In what one commentator called an “appalling” finding, 90% of patients in a recent study admitted to a hospital with a prescription opioid overdose eventually received another opioid prescription##mdash;often from the same clinician. Efforts to improve safe prescribing hope to fix the problem.
https://immattersacp.org/archives/2016/10/overdose.htm
1 Oct 2016
Statin warnings on liver enzymes, blood glucose revised
The warning labels on statin medications are being changed, the FDA announced last week.
https://immattersacp.org/weekly/archives/2012/03/06/7.htm
6 Mar 2012
Latest diabetes drugs have a learning curve
The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015
New safety labels added to entire class of fluoroquinolones
Oral and injectable fluoroquinolones are associated with side effects involving tendons, muscles, joints, nerves, and the central nervous system, an FDA safety review found. These side effects may occur hours to weeks after use and can be permanent.
https://immattersacp.org/weekly/archives/2016/08/02/5.htm
2 Aug 2016